tiprankstipranks
Trending News
More News >
GenSight Biologics SA (FR:SIGHT)
:SIGHT
France Market

GenSight Biologics SA (SIGHT) Income Statement

Compare
3 Followers

GenSight Biologics SA Income Statement

Last quarter (Q2 2025), GenSight Biologics SA's total revenue was €48.00K, a decrease of -96.90% from the same quarter last year. In Q2, GenSight Biologics SA's net income was €-6.97M. See GenSight Biologics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 2.63M€ 1.27M€ 2.58M€ 5.28M€ 4.39M
Gross Profit
€ 2.63M€ 3.00M€ 2.58M€ 5.28M€ 4.39M
Operating Expenses
€ 18.44M€ 32.66M€ 30.42M€ 33.40M€ 29.33M
Depreciation and Amortization
€ 1.06M€ 3.03M€ 1.06M€ 928.00K€ 926.00K
EBITDA
€ -14.76M€ -21.73M€ -26.77M€ -25.52M€ -34.13M
Operating Income
€ -15.81M€ -29.70M€ -27.84M€ -28.13M€ -24.93M
Other Income/Expenses
€ 1.83M€ 3.48M€ 215.00K€ -489.00K€ -9.08M
Pretax Income
€ -13.98M€ -26.22M€ -27.62M€ -28.61M€ -34.01M
Net Income
€ -14.00M€ -26.22M€ -27.62M€ -28.62M€ -34.02M
Per Share Metrics
Basic EPS
€ -0.15€ -0.54€ -0.60€ -0.63€ -0.97
Diluted EPS
€ -0.15€ -0.54€ -0.60€ -0.63€ -0.97
Weighted Average Shares Outstanding
95.76M 48.32M 46.33M 45.15M 35.13M
Weighted Average Shares Outstanding (Diluted)
95.76M 48.32M 46.33M 45.15M 35.13M
Currency in EUR

GenSight Biologics SA Earnings and Revenue History